fda glp-1 warning letters september 2025 news Beyond the Headlines: to Compounders Moderna, Prime Medicine, UnitedHealth: Readout

Overall, patient accounts convey enthusiasm and satisfaction in many cases, especially when follow-up treatments or proper skincare accompany GHK-Cu

For 503B outsourcing facilities, no equivalent safe harbor appears to apply, and enforcement grace periods that had been in place through early 2026 are expiring, leaving bulk compounders of GLP-1s in a substantially more precarious legal position

[4] [5] Research has investigated berberine's potential effects on blood glucose control, lipid profiles, and body weight, though it is not licensed as a medicine by the MHRA in the UK and is sold as a food supplement or herbal product with variable quality

F., Hu, M

If you have concerns about your digestive health, start with a comprehensive medical assessment to explore your options

Timeline: When You'll Notice Weight Loss Changes Most patients begin noticing appetite suppression within the first 12 weeks of starting GLP-1 therapy, though visible weight loss typically appears around weeks 36